Document is current
Any future updates will be listed below
-
Authors
Kuriakose Kuzhiyanjal, Anish J. https://orcid.org/0000-0002-5161-1747
Subramanian, Sreedhar https://orcid.org/0000-0002-6483-1730
Limdi, Jimmy K. https://orcid.org/0000-0002-1039-6251
- License Information
-
More Information
Article History
Received: 29 December 2024
Accepted: 7 January 2025
First Online: 22 January 2025
Declarations
:
: Anish Kuzhiyanjal has received chairing fees from Dr. Falk Pharma. Sreedhar Subramanian has received speaker fees from MSD, Actavis, AbbVie, Dr. Falk Pharma, Ipsen, and Shire; received educational grants from MSD, AbbVie, and Actavis; and served on the advisory board for AbbVie, Dr. Falk Pharma, and Vifor Pharma. Jimmy K. Limdi has received speaker or consultancy fees from Abbvie, Arena, Abivax, Alphasigma, Bristol Myers Squibb, Celltrion, Eli Lilly, Janssen, MSD, Pfizer and Takeda and research grants from Galapagos and Takeda.
: This was an audit and service evaluation study and as such exempt from ethical approval.
